Sartorius Stedim Biotech S.A.

ENXTPA:DIM Stock Report

Market Cap: €26.4b

Sartorius Stedim Biotech Balance Sheet Health

Financial Health criteria checks 3/6

Sartorius Stedim Biotech has a total shareholder equity of €2.7B and total debt of €3.6B, which brings its debt-to-equity ratio to 133.5%. Its total assets and total liabilities are €7.7B and €5.1B respectively. Sartorius Stedim Biotech's EBIT is €468.7M making its interest coverage ratio 4.3. It has cash and short-term investments of €126.1M.

Key information

133.5%

Debt to equity ratio

€3.57b

Debt

Interest coverage ratio4.3x
Cash€126.10m
Equity€2.67b
Total liabilities€5.07b
Total assets€7.74b

Recent financial health updates

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)

Feb 19
Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)

Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear

Dec 22
Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear

Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

Dec 01
Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Nov 10
Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Aug 23
Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly

May 25
Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly

Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching

May 09
Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching

Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Apr 23
Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly

Feb 07
Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly

Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?

Jan 20
Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?

Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet

Nov 09
Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet

Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today

Oct 20
Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today

Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

Oct 03
Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt

Jul 26
We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt

Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?

Jul 09
Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?

Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value

Jun 21
Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value

Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Apr 21
Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock

Apr 03
Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock

We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit

Feb 24
We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit

Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Dec 04
Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Aug 21
Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

May 10
Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

Sartorius Stedim Biotech S.A.'s (EPA:DIM) CEO Will Probably Have Their Compensation Approved By Shareholders

Mar 17
Sartorius Stedim Biotech S.A.'s (EPA:DIM) CEO Will Probably Have Their Compensation Approved By Shareholders

Here's What Sartorius Stedim Biotech S.A.'s (EPA:DIM) Shareholder Ownership Structure Looks Like

Mar 14
Here's What Sartorius Stedim Biotech S.A.'s (EPA:DIM) Shareholder Ownership Structure Looks Like

Financial Position Analysis

Short Term Liabilities: DIM's short term assets (€1.4B) exceed its short term liabilities (€937.3M).

Long Term Liabilities: DIM's short term assets (€1.4B) do not cover its long term liabilities (€4.1B).


Debt to Equity History and Analysis

Debt Level: DIM's net debt to equity ratio (128.7%) is considered high.

Reducing Debt: DIM's debt to equity ratio has increased from 12.7% to 133.5% over the past 5 years.

Debt Coverage: DIM's debt is well covered by operating cash flow (20.9%).

Interest Coverage: DIM's interest payments on its debt are well covered by EBIT (4.3x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.